Carnot ICM
The ICM Carnot Institute, also known as Paris Brain Institute, is located in Paris at the heart of the Pitié-Salpêtrière Hospital.
Its innovative model brings more than 700 researchers, a clinical investigation center and a large startup accelerator. Paris Brain Institute has structured its research strategy into major thematic areas and cross-disciplinary research needs in the field of Neurosciences. Its mission is to accelerate the development of new technologies in the fields of neurology, psychiatry and cognition.
Economic sectors
And also
Key figures
| Permanent staff (full-time equivalent) | 447 |
| PhD Students | 85 |
| Global budget | 48,9 M€ |
| Partnership incomes with industry | 11,1 M€ |
Contact
institut Carnot ICM
Hôpital Pitié-Salpétrière,
47/83 boulevard de l'hôpital
75013 Paris
France
Research & Technology Development Division
partnership@icm-institute.org
Presentation
Personalized Medicine
Paris Brain Institute has structured its research strategy into major thematic and transversal axis adapted to the unsatisfied needs of "translational" research in the field of Neurosciences.
With large cohorts of patients and top-notch neuro-imaging and “omics” facilities, biomarkers and new therapeutic targets can be identified at accelerated rate for diseases ranging from Parkinson's disease, Alzheimer's disease, multiple sclerosis, to epilepsy, psychiatric diseases and neuro-oncological tumors. Some are already in routine use at the Institute for a personalized diagnosis and a prediction of responses to treatments.
Solutions for drug, medtech, digital Tx development:
- Drug development platform
- Prototyping of medical technologies
- Early clinical research
- Prevention approaches
-
Deeptech start-ups acceleration
- Social good entrepreneurship
Target markets
- Pharmacy
- Biotechnology
- Medical technology
- Digital health
Skills:
- Genetic
- Cell imaging
- Preclinical tests
-
Biomarker research
- Clinical research
- Patients cohort
- Neuroimaging
- Biostatistics
- Digital tools development
New technologies for healthcare:
“Biomarkers” can be applied for diagnosis and prognosis of disease progression. In the field of neurosciences, they can also easily been made accessible at home with non-invasive neurotechnology devices measuring cognition, behavior, brain activity and allowing each individual person to monitor its health parameters and become an actor of its own treatment.
Technologies can also be the therapy itself: deep brain stimulation for movement disorders, therapeutic ultrasounds, transcranial magnetic stimulation, etc. are developed at the ICM Carnot Institute thanks to the support of 7,000 m² of technological platforms.
Health key numbers:
- 25 research teams, 11 of which are international
- More than 4500 publications since 2012
- 10 technological platforms
